Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
MedAlliance announces completion of enrollment in Japanese SELUTION SLR™ Study 2021-09-23 08:00
INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico 2021-09-22 20:00
LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser for Treatment of Varicose Vein. 2021-09-22 03:04
Novavax to Participate in Fireside Chat at Devex @ UNGA 76 2021-09-21 04:46
RhoVac announces the completion of patient recruitment for the BRaVac clinical phase IIb study of RV001 in prostate cancer 2021-09-21 04:06
Terumo celebrates 100-year anniversary in Asia with an eye to the future 2021-09-20 10:00
Illumina reaffirms commitment to the National Project of Bio Big Data in Korea 2021-09-20 07:00
Innovent Releases Interim Analysis Results of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma in the Phase 3 ORIENT-15 Study at ESMO Congress 2021 2021-09-18 08:00
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021 2021-09-17 19:00
Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment 2021-09-17 18:30
BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone 2021-09-17 15:00
Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients with Advanced Cholangiocarcinoma at ESMO Congress 2021 2021-09-17 08:00
PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale 2021-09-17 03:59
Beyond Ventures' first investment, Prenetics, becomes first Hong Kong unicorn to go public 2021-09-16 15:31
SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria 2021-09-16 08:45
Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H 2021-09-14 10:30
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval 2021-09-13 19:00
FUJIFILM Diosynth Biotechnologies and NeuExcell Therapeutics enter manufacturing agreement to rapidly advance NXL-001, a potential neuro-regeneration gene therapy to treat ischemic cortical stroke 2021-09-13 18:00
Hummingbird Bioscience Announces US FDA Clearance of IND for First-in-Human Phase 1 Trial of HMBD-002 in Patients with Advanced Solid Tumors 2021-09-13 17:00
Everest Medicines Enters into Comprehensive Agreements with Providence Therapeutics to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Asia Emerging Markets 2021-09-13 17:00
1 101 102 103 104 105 211